Amphastar Pharmaceuticals (AMPH) Receivables - Other (2021 - 2025)
Amphastar Pharmaceuticals (AMPH) recorded quarterly Receivables - Other of $500000.0 in Q2 2025, up 150.0% quarter-over-quarter from $200000.0 in Q1 2025, and up 66.67% on a YoY basis from $300000.0 in Q2 2024.
Amphastar Pharmaceuticals (AMPH) Receivables - Other (2021 - 2025) Analysis & Trends
Amphastar Pharmaceuticals' Receivables - Other history runs 4 years deep, the most recent figure standing at $500000.0 for Q2 2025.
- In Q2 2025, Receivables - Other rose 66.67% year-over-year to $500000.0; the TTM figure through Jun 2025 stood at $500000.0 (up 66.67% YoY), while the FY2024 annual figure was $200000.0, changed N/A from the prior year.
- Receivables - Other was $500000.0 for Q2 2025 at Amphastar Pharmaceuticals, up from $200000.0 in the prior quarter.
- In the past five years, Receivables - Other ranged from a high of $2.5 million in Q3 2021 to a low of $200000.0 in Q3 2022.
- Historically, Receivables - Other has averaged $555555.6 across 4 years, with a median of $300000.0 in 2024.
- The sharpest annual moves came in 2022 and 2025: Receivables - Other tumbled 92.0% in 2022, then surged 66.67% in 2025.
- A 4-year view of Receivables - Other shows it stood at $2.5 million in 2021, then plunged by 84.0% to $400000.0 in 2022, then tumbled by 50.0% to $200000.0 in 2024, then jumped by 150.0% to $500000.0 in 2025.
- The last three Receivables - Other figures came in at $500000.0 (Q2 2025), $200000.0 (Q1 2025), and $200000.0 (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Amphastar Pharmaceuticals | 914.14 Mn | 914.14 Mn | 70.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 500,000.00 |
| Jun 30, 2025 | 500,000.00 |
| Mar 31, 2025 | 200,000.00 |
| Mar 31, 2025 | 200,000.00 |
| Dec 31, 2024 | 200,000.00 |
| Dec 31, 2024 | 200,000.00 |
| Sep 30, 2024 | 400,000.00 |
| Sep 30, 2024 | 400,000.00 |
| Jun 30, 2024 | 300,000.00 |
| Jun 30, 2024 | 300,000.00 |
| Mar 31, 2024 | 300,000.00 |
| Mar 31, 2024 | 300,000.00 |
| Dec 31, 2022 | 400,000.00 |
| Dec 31, 2022 | 400,000.00 |
| Sep 30, 2022 | 200,000.00 |
| Sep 30, 2022 | 200,000.00 |
| Sep 30, 2021 | 2.50 Mn |
| Sep 30, 2021 | 2.50 Mn |